Results 161 to 170 of about 34,952,696 (369)

Circulating tumor DNA (ctDNA) trajectories predict survival in trifluridine/tipiracil‐treated metastatic colorectal cancer patients

open access: yesMolecular Oncology, EarlyView.
The authors applied joint/mixed models that predict mortality of trifluridine/tipiracil‐treated metastatic colorectal cancer patients based on circulating tumor DNA (ctDNA) trajectories. Patients at high risk of death could be spared aggressive therapy with the prospect of a higher quality of life in their remaining lifetime, whereas patients with a ...
Matthias Unseld   +7 more
wiley   +1 more source

Matching Triangles and Basing Hardness on an Extremely Popular Conjecture

open access: yesSymposium on the Theory of Computing, 2015
Amir Abboud, V. V. Williams, Huacheng Yu
semanticscholar   +1 more source

Integrative analysis of circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients: a comprehensive approach

open access: yesMolecular Oncology, EarlyView.
This study simultaneously investigated circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients. The elevated expression of JUNB and CXCR4 in CTCs was a poor prognostic factor for SCLC patients, whereas exosomal overexpression of these biomarkers revealed a high discrimination ability of patients from healthy individuals,
Dimitrios Papakonstantinou   +13 more
wiley   +1 more source

THE ULIANOV CHUVASH STATE UNIVERSITY: BASING ON TRADITIONS TO INNOVATIONS

open access: yesВысшее образование в России, 2016
The article presents the historical path, the current state and the development prospects of the largest university in the Chuvash Republic - The Ulianov Chuvash State University.
Andrey Yu. Aleksandrov   +1 more
doaj  

On Basing Private Information Retrieval on NP-Hardness

open access: yesTheory of Cryptography Conference, 2016
Tianren Liu, V. Vaikuntanathan
semanticscholar   +1 more source

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR

open access: yesMolecular Oncology, EarlyView.
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy